Patent: 8,569,348
✉ Email this page to a colleague
Summary for Patent: 8,569,348
Title: | Compounds, compositions, and methods for preventing metastasis of cancer cells |
Abstract: | Disclosed are methods for preventing metastasis of cancer cells. The disclosed compounds can be used to prevent the spread of tumor or other types of cancer cells. |
Inventor(s): | Shalwitz; Robert (Bexley, OH), Peters; Kevin G. (Cincinnati, OH) |
Assignee: | Aerpio Therapeutics Inc. (Cincinnati, OH) |
Application Number: | 12/677,550 |
Patent Claims: | see list of patent claims |
Details for Patent 8,569,348
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2029-06-06 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2029-06-06 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2029-06-06 | |
Hemispherx Biopharma, Inc. | ALFERON N INJECTION | interferon alfa-n3 (human leukocyte derived) | Injection | 103158 | 10/10/1989 | ⤷ Try a Trial | 2029-06-06 |
Clinigen, Inc. | PROLEUKIN | aldesleukin | For Injection | 103293 | 05/05/1992 | ⤷ Try a Trial | 2029-06-06 |
Servier Pharmaceuticals Llc | ONCASPAR | pegaspargase | Injection | 103411 | 02/01/1994 | ⤷ Try a Trial | 2029-06-06 |
Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | 02/26/2004 | ⤷ Try a Trial | 2029-06-06 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |